Join to View Full Profile
9500 Euclid AveBuilding U10Cleveland, OH 44195
Phone+1 216-444-8600
Fax+1 216-445-6259
Dr. Bermel is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Cleveland Clinic FoundationResidency, Neurology, 2003 - 2007
Jacobs School of Medicine and Biomedical Sciences at the University at BuffaloClass of 2003
Certifications & Licensure
FL State Medical License 2024 - 2026
NY State Medical License 2024 - 2025
OH State Medical License 2003 - 2025
NV State Medical License 2012 - 2023
American Board of Psychiatry and Neurology Neurology
Clinical Trials
- Optical Coherence Tomography in Multiple Sclerosis Patients Start of enrollment: 2012 Aug 01
Publications & Presentations
PubMed
- A digital version of the nine-hole peg test: Speed may be a more reliable measure of upper-limb disability than completion time in patients with multiple sclerosis.Xiaotong Jiang, Marisa McGinley, Joshua Johnston, Jay Alberts, Robert Bermel
Multiple Sclerosis. 2025-01-01 - Ocrelizumab in Early-Stage Relapsing-Remitting Multiple Sclerosis: The Phase IIIb ENSEMBLE 4-Year, Single-Arm, Open-Label Trial.Hans-Peter Hartung, Ralph H B Benedict, Thomas Berger, Robert A Bermel, Bruno Brochet
Neurology. 2024-12-24 - Subcutaneous ocrelizumab in multiple sclerosis: Results of the Phase 1b OCARINA I study.Scott D Newsome, Lawrence Goldstick, Derrick S Robertson, James D Bowen, Robert T Naismith
Annals of Clinical and Translational Neurology. 2024-12-01
Journal Articles
- Outer Retinal Assessment Using Spectral-Domain Optical Coherence Tomography in Patients with Alzheimer's and Parkinson's DiseaseHubert Fernandez, Justis P Ehlers, Jagan A Pillai, Sunil K Srivastava, Robert Bermel, James B Leverenz, Investigative Ophthalmology and Visual Science
Authored Content
- Optical Coherence Tomography Outcomes from SPRINT-MS, a Multicenter, Randomized, Double-Blind Trial of Ibudilast in Progressive Multiple SclerosisOctober 2020
Press Mentions
Higher-Dosed Ocrelizumab Associated with Less Disability AccrualMarch 27th, 2025- How B-cell Therapy Affects MSFebruary 7th, 2023
- World-First Study Charts Brain Decline as We AgeApril 7th, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
